Cervical length changes during preterm cervical ripening: effects of 17α-hydroxyprogesterone caproate

American Journal of Obstetrics and Gynecology

Volumn 196, Issue 5, 2007, Pages 421-

  Meis, Paul J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

DRUG EFFECT; DRUG EFFICACY; EDITORIAL; PREMATURE LABOR; PRIORITY JOURNAL; TOCOLYSIS; TREATMENT OUTCOME; UTERINE CERVIX RIPENING;

EID: 34247206524     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.09.024     Document Type: Editorial

References (7)

1. Facchinetti F., Paganelli S., Comitini G., Dante G., and Volpe A. Cervical length changes during preterm cervical ripening: effects of 17α-hydroxy-progesterone caproate. Am J Obstet Gynecol 196 (2007) XXXX
2. Fuchs F., and Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 79 (1960) 172-176
3. Erny R., Pigne A., Prouvost C., et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 154 (1986) 525-529
4. Noblot G., Audra P., Dargent D., et al. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 40 (1991) 203-209
5. Meis P.J., Klebanoff M., Thom E., et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate [published erratum appears in N Engl J Med 2003;349:1299]. N Engl J Med 348 (2003) 2379-2385
6. Sanchez-Ramos L., Kaunitz A.M., and Delke I. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials. Obstet Gynecol 105 (2005) 273-279
7. The Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 327 (1992) 308-312